Jia Pei Lim

Research Interests

Epigenetics Cancer Cell Biology

Miss Jia Pei Lim

ARC Grant-Funded Research Fellow

SAIGENCI

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

Dr. Jia Pei Lim is a postdoctoral researcher at the South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, with a strong background in cancer epigenetics and 3D chromatin biology. Her research focuses on histone methyltransferases and chromatin-modifying complexes in cancer, working under the supervision of Dr. Qi Zhang.Dr. Lim has led high-impact research across institutions in Singapore, Sweden, and Australia. She completed her PhD in Cancer Biology at the National University of Singapore and previously held a postdoctoral position at Karolinska Institutet. Her work has resulted in nine peer-reviewed publications, including a co-first author paper in Nature Communications and a co-authored paper in Science Translational Medicine. Her research has been cited over 370 times (H-index: 9).She is actively involved in the scientific community through conference presentations (e.g. CSHL, EMBL, AACR), professional memberships, and collaborative research with leading institutes such as RIKEN and A*STAR. Dr. Lim also serves on the SAiGENCI Early Career Researcher (ECR) Committee.

Date Position Institution name
2025 - ongoing Post-doctoral researcher University of Adelaide
2019 - 2023 Post-doctoral researcher Karolinska Institute

Date Type Title Institution Name Country Amount
2014 Scholarship Ong Hin Tiang Scholarship in Cancer Research National University of Singapore Singapore -

Language Competency
Chinese (Mandarin) Can read, write, speak and understand spoken
English Can read, write, speak, understand spoken and peer review
Malay Can read, write, speak and understand spoken

Date Institution name Country Title
2014 - 2019 National University of Singapore Singapore PhD
2008 - 2012 Universiti Putra Malaysia Malaysia Bachelor of Biomedical Sciences

Year Citation
2024 Neo, S. Y., Tong, L., Chong, J., Liu, Y., Jing, X., Oliveira, M. M. S., . . . Lundqvist, A. (2024). Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis. SCIENCE TRANSLATIONAL MEDICINE, 16(747), 18 pages.
DOI Scopus56 WoS50 Europe PMC41
2022 Chachoua, I., Tzelepis, I., Dai, H., Lim, J. P., Lewandowska-Ronnegren, A., Casagrande, F. B., . . . Göndör, A. (2022). Canonical WNT signaling-dependent gating of MYC requires a noncanonical CTCF function at a distal binding site. Nature Communications, 13(1), 204.
DOI Scopus19 WoS19 Europe PMC21
2019 Lim, J. P., Nair, S., Shyamasundar, S., Chua, P. J., Muniasamy, U., Matsumoto, K., . . . Bay, B. H. (2019). Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression. Cancer Letters, 452, 119-131.
DOI Scopus51 WoS50 Europe PMC47
2018 Chua, P. J., Lim, J. P., Guo, T. T., Khanna, P., Hu, Q., Bay, B. H., & Baeg, G. H. (2018). Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells. International Journal of Oncology, 53(6), 2579-2589.
DOI Scopus24 WoS25 Europe PMC24
2018 Soh, R. Y. Z., Lim, J. P., Samy, R. P., Chua, P. J., & Bay, B. H. (2018). A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer. Experimental and Molecular Pathology, 105(3), 364-370.
DOI Scopus20 WoS19 Europe PMC16
2018 Lim, J. P., Nair, S., Shyamasundar, S., Gunaratne, J., & Bay, B. H. (2018). Advanced quantitative mass-spectrometry-based SILAC proteome profiling of Y-box binding protein-1 (YB-1) overexpressing breast cancer cells unravels proteins involved in metastasis. CANCER RESEARCH, 78(13), 2 pages.
DOI
2017 Lim, J. P., Shyamasundar, S., Gunaratne, J., Scully, O. J., Matsumoto, K., & Bay, B. H. (2017). YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro. BMC Cancer, 17(1), 15 pages.
DOI Scopus64 WoS67 Europe PMC65
2017 Lim, J. P., Baeg, G. H., Srinivasan, D. K., Dheen, S. T., & Bay, B. H. (2017). Potential adverse effects of engineered nanomaterials commonly used in food on the miRNome. Food and Chemical Toxicology, 109(Pt 1), 771-779.
DOI Scopus24 WoS17 Europe PMC10
2016 Shyamasundar, S., Lim, J. P., & Bay, B. H. (2016). MiR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1. International Journal of Oncology, 49(6), 2629-2636.
DOI Scopus59 WoS59 Europe PMC51
2014 Lim, J. P., Devaux, J., & Yuki, N. (2014). Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmunity Reviews, 13(10), 1070-1078.
DOI Scopus35 WoS28 Europe PMC27

Date Role Research Topic Program Degree Type Student Load Student Name
2026 Co-Supervisor Epigenetic dysregulation in human development and cancer - Doctorate Full Time Miss Angela Kloutsiniotis
2025 Co-Supervisor Cancer Epigenetics Doctor of Philosophy Doctorate Full Time Ms Suchandana Deka
2025 Co-Supervisor Investigating the role of epigenetic regulation in neural development and disease Doctor of Philosophy Doctorate Full Time Miss Ruoxuan Jia
2025 Co-Supervisor Investigating the role of epigenetic regulation in neural development and disease Doctor of Philosophy Doctorate Full Time Ruoxuan Jia
2025 Co-Supervisor Cancer Epigenetics Doctor of Philosophy Doctorate Full Time Ms Suchandana Deka

Date Role Committee Institution Country
2025 - ongoing Member SAiGENCI ECR Committee SAiGENCI Australia
2015 - 2017 Board Member Safety Committee National University of Singapore Singapore

Date Role Membership Country
2018 - 2019 Member Microscopy Society (Singapore) Singapore
2017 - ongoing Member American Association for Cancer Research (AACR) United States
2017 - 2023 Member European Association for Cancer Research (EACR) United Kingdom
2017 - 2022 Member Singapore Society for Mass Spectrometry (SSMS) Singapore

Connect With Me

External Profiles

Other Links